{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:18:26Z","timestamp":1788344306331,"version":"build-2803163510"},"reference-count":88,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Simultaneous blockade of the anti\u2010apoptotic proteins BCL\u20102 and BCL\u2010XL has been shown to be efficacious in preclinical and clinical trials for tumors that are co\u2010dependent on their survival pathways, although clinical development has been limited owing to dose\u2010limiting thrombocytopenia associated with BCL\u2010XL inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Recent developments have provided strategies that are largely complementary, attempting to separate anti\u2010tumor activity from platelet toxicity: (I) targeted protein degraders (PROTACs) that recruit E3 ligases weakly expressed in platelets to spare platelet BCL\u2010XL, (II) prodrug and formulation strategies that preferentially deliver active drug concentrations to the tumor, (III) dosing and scheduling to leverage catalytic or durable mechanisms of action, and (IV) rational combination regimens that reduce per\u2010agent exposure while retaining or enhancing anti\u2010tumor activity. This perspective will integrate the mechanistic rationale, preclinical support, and emerging clinical evidence supporting these mechanisms and propose the next steps and sequencing for future experimental or clinical directions to explore safe and active dual BCL\u20102\/BCL\u2010XL therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these emerging strategies offer an opportunity to develop dual BCL\u20102\/BCL\u2010XL inhibitors with greater anti\u2010tumor activity while minimizing thrombocytopenia and potentially broadening their clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hsr2.72506","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T03:56:33Z","timestamp":1778471793000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL\u20102\/BCL\u2010XL Inhibition"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-8655","authenticated-orcid":false,"given":"Md","family":"Mohiuddin","sequence":"first","affiliation":[{"name":"Department of Pharmacy Southeast University Dhaka Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/524308"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00697"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-25-0096"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060528"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207591"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08205-8"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-026-04671-9"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402081"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.6208"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-344812"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27248828"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112186"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30102123"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.27.582353"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0668-z"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281915"},{"key":"e_1_2_12_19_1","first-page":"1","article-title":"Targeting BCL\u2010xL to Eliminate Chemotherapy\u2010Induced Tumor Dormancy and Prevent Breast Cancer Metastasis: Translational Therapeutics","volume":"134","author":"Gupta K.","year":"2025","journal-title":"British Journal of Cancer"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2020.00017"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00568"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.3177.3177"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12457"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29009"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c03330"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmcr.2026.100332"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1505255"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2024.2415310"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0668-z"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112186"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-125820"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-114762"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01753-8"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178813"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.24.661170"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00928-9"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100689"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-184887"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-CT063"},{"issue":"10","key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"B004","DOI":"10.1158\/1535-7163.TARG-25-B004","article-title":"Abstract B004: Phase 1b Trial of BCL\u2010xL Degrader DT2216 and Weekly Paclitaxel in Recurrent Platinum\u2010Resistant Ovarian Cancer","volume":"24","author":"Stover E. H.","year":"2025","journal-title":"Molecular Cancer Therapeutics"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.037"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.75421"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2025.102593"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030988"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101454"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100689"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1525"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01631-8"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008017"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.12.012"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17162628"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smaim.2025.07.004"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28104014"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01672-1"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92889.3"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S299591"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S80646"},{"key":"e_1_2_12_58_1","first-page":"37","article-title":"Romiplostim as a Treatment for Immune Thrombocytopenia: A Review","volume":"6","author":"Chalmers S.","year":"2015","journal-title":"Journal of Blood Medicine"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.1133.1133"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.3504.3504"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1810815"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347849"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1409461"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1365"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204207"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013194"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04262-x"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-1737"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-13-C250"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-6223"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.144"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5505"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-180190"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01296-8"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-24-0873"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn6579"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210750"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133289"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.215871.113"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.215855.113"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00173.2013"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.COT.0000546176.37345.77"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-0868-6"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2020.00017"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.3509"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.2594"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00517"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.15212\/AMM-2022-0022"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102310"}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.72506","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hsr2.72506","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.72506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:55:50Z","timestamp":1788342950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.72506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/hsr2.72506"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.72506","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"value":"2398-8835","type":"print"},{"value":"2398-8835","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72506"}}